Evidence map›Paper›PMID 40059696›Full record

ArticleTransfusion2025

Nationwide estimates of potential lives saved with prehospital blood transfusions.

Daniel T Lammers, Richard Betzold, Reynold Henry, Joshua Dilday, Jeffrey R Conner, James M Williams, John M McClellan, Matthew J Eckert, Jan O Jansen, Jeffrey Kerby and 2 more

Abstract read
In one paragraph

Article in Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel T LammersUniversity of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
Richard BetzoldUniversity of Arkansas Medical School, Little Rock, Arkansas, USA.
Reynold HenryUniversity of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0002-2662-5485
Joshua DildayMedical College of Wisconsin, Milwaukee, Wisconsin, USA.
Jeffrey R ConnerWake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
James M WilliamsMadigan Army Medical Center, Tacoma, Washington, USA.
John M McClellanUniversity of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
Matthew J EckertUniversity of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
Jan O JansenCenter for Injury Science, University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0001-8863-4398
Jeffrey KerbyCenter for Injury Science, University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA.
John B HolcombCenter for Injury Science, University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0001-8312-9157
Zain G HashmiCenter for Injury Science, University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0002-5867-0272

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrehospital blood transfusions result in a significant reduction in mortality risk for injured patients in hemorrhagic shock; however, prehospital blood transfusions have not been widely implemented across the United States. Thus, a paucity of data surrounding the impact of achieving near-complete population-level access to this resource exists. We aimed to determine the number of lives that could potentially have been saved among injured patients in hemorrhagic shock between 2020 and 2023 had prehospital blood products (blood components or whole blood, pBP) been fully implemented.

methodsWe performed a retrospective review of the National Emergency Medical Services Information System (NEMSIS) from 2020 to 2023 for all trauma patients ≥16 years. Patients with prehospital systolic blood pressure <90 mmHg and heart rate >108 beats per minute, or a systolic blood pressure <70 mmHg, and who did not receive pBP products were included in the analysis. Potential lives saved were calculated using mortality and risk ratio estimates (RR) from previously published studies, assuming 100% nationwide access to pBP. A series of models were developed incorporating varying RR, mortality rate assumptions, and nationwide access to pBP to encompass a wide range of scenarios.

resultsA total of 260,472 patients met our inclusion criteria. Using a 22.1% 24-h mortality rate and an RR of 0.629, 21,356 deaths over the four-year study period could have potentially been saved with the nationwide implementation of pBP.

conclusionTransfusion of pBP offers the potential to save thousands of injured patients lives. Efforts toward making policy-level interventions aimed at increasing the adoption and availability of pBP should be sought.

Indexed as

Blood TransfusionEmergency Medical ServicesShock, HemorrhagicWounds and InjuriesAdolescentAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesUnited StatesYoung Adultblood transfusionhemorrhagic shockprehospitalprehospital blood products

Identifiers

PMID40059696
PMCPMC12035975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.